Erasca Announces FDA Clearance of IND Application for ERAS-801 in Glioblastoma Multiforme and Collaboration with GCAR for Potential Inclusion in GBM AGILE Clinical Trial

by NASDAQ Market News December 17, 2021

NASDAQ Market News
Click here to email author

Xevudy (Sotrovimab) Granted Marketing Authorization by the European Commission for the Early Treatment of COVID-19

Century Therapeutics Added to the NASDAQ Biotechnology Index

Ads